The XENERA™-1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Post-menopausal Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread
about
The XENERA™-1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Post-menopausal Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread
description
clinical trial
@en
klinisch onderzoek
@nl
name
The XENERA™-1 Study Tests Xent ...... Breast Cancer That Has Spread
@en
type
label
The XENERA™-1 Study Tests Xent ...... Breast Cancer That Has Spread
@en
prefLabel
The XENERA™-1 Study Tests Xent ...... Breast Cancer That Has Spread
@en
P17
P4844
P6153
P1476
XENERA™-1: A Multi-centre, Dou ...... ancer and Non-visceral Disease
@en
P3098
NCT03659136
P580
2018-11-28T00:00:00Z
P582
2020-12-14T00:00:00Z